Providence First Trust’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$752K Buy
5,849
+1,370
+31% +$160K 0.21% 117
2026
Q1
$539K Buy
+4,479
New +$517K 0.19% 118
2025
Q1
Sell
-135
Closed -$13.4K 158
2024
Q4
$13.4K Buy
+135
New +$13.9K 0.01% 176
2024
Q1
Sell
-6,725
Closed -$733K 106
2023
Q4
$733K Hold
6,725
0.36% 65
2023
Q3
$692K Sell
6,725
-2,120
-24% -$228K 0.39% 63
2023
Q2
$1.02M Buy
+8,845
New +$1M 0.56% 51

Other funds holding MRK

Providence First Trust's MRK Position: Q2 2026 in Review

Providence First Trust increased its Merck (MRK) stake by 31% in Q2 2026, buying an estimated $160K and bringing the position to 5,849 shares worth $752K. The position accounts for 0.21% of the portfolio, ranked #117.

Providence First Trust first reported a position in MRK in Q2 2023 and has held it in 6 quarters since. The position peaked at $1.02M in Q2 2023. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Providence First Trust held 5,849 shares of Merck worth $752K as of Q2 2026.
  • Providence First Trust bought 1,370 Merck shares in Q2 2026, an estimated $160K.
  • Merck made up 0.21% of Providence First Trust's portfolio in Q2 2026, its #117 holding.
  • Providence First Trust first reported a position in Merck in Q2 2023 and has held it in 6 quarters since.
  • Providence First Trust's Merck position peaked at $1.02M in Q2 2023.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Providence First Trust's 13F filing for Q2 2026, filed 27 Jul 2026.